These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2823600)

  • 21. Enteric-coated aspirin in rheumatoid arthritis.
    Bird HA; Rhind V; Leatham P; Saunders A; Wright V
    Rheumatol Rehabil; 1981 May; 20(2):116-21. PubMed ID: 6792691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drugs, gastritis, and peptic ulcer.
    Ivey KJ
    J Clin Gastroenterol; 1981; 3(Suppl 2):29-34. PubMed ID: 7320467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood salicylate levels and clinical trials with a new form of enteric-coated aspirin: studies in rheumatoid arthritis and degenerative joint disease.
    Baum J
    J Clin Pharmacol J New Drugs; 1970; 10(2):132-7. PubMed ID: 4906542
    [No Abstract]   [Full Text] [Related]  

  • 24. Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis.
    Hawthorne AB; Mahida YR; Cole AT; Hawkey CJ
    Br J Clin Pharmacol; 1991 Jul; 32(1):77-83. PubMed ID: 1888645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspirin--a national survey V: Determination of aspirin and impurities in enteric coated tablets and suppository formulations and in vitro dissolution of enteric coated tablets.
    Kirchhoefer RD; Jefferson E; Flinn PE
    J Pharm Sci; 1982 Sep; 71(9):1049-52. PubMed ID: 7131273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [RISKS IN THERAPY. GASTRODUODENAL LESIONS CAUSED BY ACETYLSALICYLIC ACID AND THEIR PROPHYLAXIS].
    LENTINI T; STOCCHI F
    Clin Ter; 1964 Apr; 29():3-31. PubMed ID: 14145523
    [No Abstract]   [Full Text] [Related]  

  • 28. Gastric emptying rates of drug preparations. II. Effects of size and density of enteric-coated drug preparations and food on gastric emptying rates in humans.
    Kaniwa N; Aoyagi N; Ogata H; Ejima A; Motoyama H; Yasumi H
    J Pharmacobiodyn; 1988 Aug; 11(8):571-5. PubMed ID: 3236215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of food on the absorption of enteric-coated aspirin: correlation with gastric residence time.
    Mojaverian P; Rocci ML; Conner DP; Abrams WB; Vlasses PH
    Clin Pharmacol Ther; 1987 Jan; 41(1):11-7. PubMed ID: 3802700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastric Outlet Obstruction--An Unexpected Complication during Coca-Cola Therapy for a Gastric Bezoar: A Case Report and Literature Review.
    Lu L; Zhang XF
    Intern Med; 2016; 55(9):1085-9. PubMed ID: 27150859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endoscopic removal of pharmacobezoar in case of intentional potassium overdose.
    Briggs AL; Deal LL
    J Emerg Med; 2014 Mar; 46(3):351-4. PubMed ID: 24113476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Failure of Computed Tomography (CT) in Detecting an Aspirin Pharmacobezoar: A Case Report.
    Parker Cote JL; Gerber BT; Lee H; Miller SN; Meggs WJ
    Am J Case Rep; 2022 Dec; 23():e936752. PubMed ID: 36536587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salicylate poisoning from enteric-coated aspirin. Delayed absorption may complicate management.
    Pierce RP; Gazewood J; Blake RL
    Postgrad Med; 1991 Apr; 89(5):61-2, 64. PubMed ID: 2008403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg) or enteric-coated aspirin 325 mg + enteric-coated omeprazole 40 mg - a randomised, phase 1, crossover study.
    Miner PB; Fort JG; Zhang Y
    Aliment Pharmacol Ther; 2013 Jul; 38(1):62-71. PubMed ID: 23692061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyloric stenosis: hold-up of enteric coated aspirin tablets.
    Harris FC
    Br J Surg; 1973 Dec; 60(12):979-81. PubMed ID: 4764749
    [No Abstract]   [Full Text] [Related]  

  • 36. Plasma salicylate levels after soluble and effervescent aspirin.
    Orton D; Treharne Jones R; Kaspi T; Richardson R
    Br J Clin Pharmacol; 1979 Apr; 7(4):410-2. PubMed ID: 444362
    [No Abstract]   [Full Text] [Related]  

  • 37. Gastric emptying of tablets and granules in humans, dogs, pigs, and stomach-emptying-controlled rabbits.
    Aoyagi N; Ogata H; Kaniwa N; Uchiyama M; Yasuda Y; Tanioka Y
    J Pharm Sci; 1992 Dec; 81(12):1170-4. PubMed ID: 1491333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between Adverse Gastric Reactions and the Timing of Enteric-Coated Aspirin Administration.
    Guo W; Lu W; Xu Y; Wang L; Wei Q; Zhao Q
    Clin Drug Investig; 2017 Feb; 37(2):187-193. PubMed ID: 27785736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment with a combination of endoscopic injection and irrigation with coca cola for gastric bezoar-induced gastric outlet obstruction.
    Lin CS; Tung CF; Peng YC; Chow WK; Chang CS; Hu WH
    J Chin Med Assoc; 2008 Jan; 71(1):49-52. PubMed ID: 18218561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Enteric-Coated Formulation of Sodium Bicarbonate on Bicarbonate Absorption and Gastrointestinal Discomfort.
    Jiang FL; Jeong DH; Eom SH; Lee HM; Cha BJ; Park JS; Kwon R; Nam JY; Yu HS; Heo SH; Kim CH; Song KH
    Nutrients; 2024 Mar; 16(5):. PubMed ID: 38474872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.